Taiwan · Delayed Price · Currency is TWD Grape King Bio Statistics
Total Valuation
Grape King Bio has a market cap or net worth of TWD 17.26 billion. The enterprise value is 14.92 billion.
| Market Cap | 17.26B |
| Enterprise Value | 14.92B |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
Grape King Bio has 148.14 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 148.14M |
| Shares Outstanding | 148.14M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 11.73% |
| Owned by Institutions (%) | 17.87% |
| Float | 115.82M |
Valuation Ratios
The trailing PE ratio is 14.26 and the forward PE ratio is 11.79.
| PE Ratio | 14.26 |
| Forward PE | 11.79 |
| PS Ratio | 1.68 |
| PB Ratio | 1.43 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | 9.95 |
| P/OCF Ratio | 7.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.53, with an EV/FCF ratio of 8.60.
| EV / Earnings | 12.25 |
| EV / Sales | 1.46 |
| EV / EBITDA | 5.53 |
| EV / EBIT | 6.87 |
| EV / FCF | 8.60 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.65 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.12 |
| Interest Coverage | 457.49 |
Financial Efficiency
Return on equity (ROE) is 15.60% and return on invested capital (ROIC) is 20.88%.
| Return on Equity (ROE) | 15.60% |
| Return on Assets (ROA) | 8.62% |
| Return on Invested Capital (ROIC) | 20.88% |
| Return on Capital Employed (ROCE) | 17.39% |
| Weighted Average Cost of Capital (WACC) | 6.16% |
| Revenue Per Employee | 20.46M |
| Profits Per Employee | 2.43M |
| Employee Count | 501 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 2.85 |
Taxes
In the past 12 months, Grape King Bio has paid 436.77 million in taxes.
| Income Tax | 436.77M |
| Effective Tax Rate | 19.01% |
Stock Price Statistics
The stock price has decreased by -14.34% in the last 52 weeks. The beta is 0.36, so Grape King Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -14.34% |
| 50-Day Moving Average | 120.40 |
| 200-Day Moving Average | 125.22 |
| Relative Strength Index (RSI) | 35.62 |
| Average Volume (20 Days) | 176,852 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Grape King Bio had revenue of TWD 10.25 billion and earned 1.22 billion in profits. Earnings per share was 8.17.
| Revenue | 10.25B |
| Gross Profit | 7.70B |
| Operating Income | 2.14B |
| Pretax Income | 2.30B |
| Net Income | 1.22B |
| EBITDA | 2.60B |
| EBIT | 2.14B |
| Earnings Per Share (EPS) | 8.17 |
Balance Sheet
The company has 4.28 billion in cash and 215.03 million in debt, with a net cash position of 4.06 billion or 27.42 per share.
| Cash & Cash Equivalents | 4.28B |
| Total Debt | 215.03M |
| Net Cash | 4.06B |
| Net Cash Per Share | 27.42 |
| Equity (Book Value) | 12.07B |
| Book Value Per Share | 69.81 |
| Working Capital | 2.24B |
Cash Flow
In the last 12 months, operating cash flow was 2.18 billion and capital expenditures -445.51 million, giving a free cash flow of 1.73 billion.
| Operating Cash Flow | 2.18B |
| Capital Expenditures | -445.51M |
| Depreciation & Amortization | 456.20M |
| Net Borrowing | -70.92M |
| Free Cash Flow | 1.73B |
| FCF Per Share | 11.71 |
Margins
Gross margin is 75.08%, with operating and profit margins of 20.89% and 11.88%.
| Gross Margin | 75.08% |
| Operating Margin | 20.89% |
| Pretax Margin | 22.41% |
| Profit Margin | 11.88% |
| EBITDA Margin | 25.34% |
| EBIT Margin | 20.89% |
| FCF Margin | 16.92% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 5.15%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 5.15% |
| Dividend Growth (YoY) | -13.04% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 83.90% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 5.16% |
| Earnings Yield | 7.06% |
| FCF Yield | 10.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.
| Last Split Date | Sep 15, 2005 |
| Split Type | Forward |
| Split Ratio | 1.0205 |
Scores
Grape King Bio has an Altman Z-Score of 5.03 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.03 |
| Piotroski F-Score | 4 |